Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

NCT01755468 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Intermittent insulin therapy
DRUG: Continuous metformin

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]